Rapport Therapeutics, Inc. (RAPP)
26.07
+1.63
(+6.67%)
USD |
NASDAQ |
Nov 09, 16:00
26.03
-0.04
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics EPS Diluted (Quarterly) : -0.8423 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.8423 |
| June 30, 2026 | -1.193 |
| March 31, 2026 | -0.4204 |
| December 31, 2025 | -0.7187 |
| September 30, 2025 | -0.7098 |
| June 30, 2025 | -0.7542 |
| March 31, 2025 | -0.6823 |
| December 31, 2024 | -0.5462 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.4795 |
| June 30, 2024 | -0.4954 |
| March 31, 2024 | -0.6198 |
| December 31, 2023 | -0.3696 |
| September 30, 2023 | -0.2381 |
| June 30, 2023 | -0.1753 |
| March 31, 2023 | -0.1681 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 0.0858 |
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.24M |
| Total Expenses (Quarterly) | 40.24M |
| Enterprise Value | 867.92M |
| Earnings Yield | -12.17% |
| Normalized Earnings Yield | -12.17 |